FDA approves Praxbind, the first reversal agent for the anticoagulant PradaxaPraxbind approved for specific emergency situationsFor Immediate Release October 16, 2015Release The U.S. Food and Drug Administration today granted accelerated approval to Praxbind (idarucizumab) for use in pa...